Blockade of growth hormone receptor signaling by using pegvisomant: A functional therapeutic strategy in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is an aggressive neoplasm with poor clinical outcome because most patients present at an advanced stage, at which point curative surgical options, such as tumor excision or liver transplantation, are not feasible. Therefore, the majority of HCC patients require systemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaseb, Ahmed O., Haque, Abedul, Vishwamitra, Deeksha, Hassan, Manal M., Xiao, Lianchun, George, Bhawana, Sahu, Vishal, Mohamed, Yehia I., Carmagnani Pestana, Roberto, Lombardo, Jamie Lynne, Avritscher, Rony, Yao, James C., Wolff, Robert A., Rashid, Asif, Morris, Jeffrey S., Amin, Hesham M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582251/
https://www.ncbi.nlm.nih.gov/pubmed/36276070
http://dx.doi.org/10.3389/fonc.2022.986305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582251/
https://www.ncbi.nlm.nih.gov/pubmed/36276070
http://dx.doi.org/10.3389/fonc.2022.986305

Ejemplares similares